Follow BDSI We are a Specialty Pharmaceutical Company with a Focus in Pain and Addiction Technology Platform Product Pipeline Conferences/Webcasts BEMA® Technology A small, dissolvable polymer film for application to mucosal membranes (inner lining of cheek) which allows for transmucosal delivery of drugs. Access Product Pipeline Publications DR. MARK A. SIRGO IS PRESENTING AT: MORGAN STANLEY GLOBAL HEALTHCARE CONFERENCE TUESDAY, SEPTEMBER 9, 2014 AT 4:40 P.M. ET CLICK HERE: 1) AUDIO WEBCAST 2) INVESTOR PRESENTATION _________________________________________________________________ BDSI INVESTOR & ANALYST UPDATE FRIDAY, SEPTEMBER 5, 2014 12:00 TO 2:00 P.M. ET CLICK HERE FOR THE REPLAY OF WEBCAST STAY INFORMED Get the latest details on our products and services. SIGN UP TOP NEWS BioDelivery Sciences to Present at the Morgan Stanley Global Healthcare Conference BioDelivery Sciences to Ring The NASDAQ Stock Market Opening Bell September 4th ceremony celebrates 2014 accomplishments including FDA approval and anticipated commercial launch of BUNAVAIL View News HOME ABOUT BDSI MANAGEMENT TEAM BOARD OF DIRECTORS CORPORATE GOVERNANCE TECHNOLOGY PLATFORM BEMA® TECHNOLOGY PRODUCT PIPELINE ONSOLIS® BEMA® BUPRENORPHINE BUNAVAIL™ INVESTOR RELATIONS SEC FILINGS SECTION 16 (INSIDER FILINGS) XBRL ANNUAL REPORT PRESENTATIONS & EVENTS INVESTOR ALERTS NEWS & MEDIA CONTACT DIRECTIONS EMPLOYMENT TERMS PRIVACY Copyright © 2014, All Rights Reserved | BioDelivery Sciences International, Inc. | Website Developed and Hosted by BizCom Web Services, Inc. | Sitemap